Biodesix Inc (BDSX) — Cash Flow-to-Debt Ratio
Biodesix Inc (BDSX) has a Cash Flow-to-Debt Ratio of -0.10x as of September 2025, meaning its operating cash flow of $-8.88 Million could theoretically repay 0% of its total liabilities ($90.44 Million) in one year. See free cash flow generation of Biodesix Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biodesix Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Biodesix Inc across 7 annual periods. Also explore net asset momentum of Biodesix Inc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Biodesix Inc (2018–2024)
Year-by-year debt coverage analysis for Biodesix Inc. For market capitalisation and broader financial context, see BDSX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.64x | $-48.65 Million | $76.37 Million | ▼ -163.3% |
| 2023 | -0.24x | $-22.87 Million | $94.52 Million | ▲ +61.1% |
| 2022 | -0.62x | $-44.97 Million | $72.30 Million | ▼ -24.2% |
| 2021 | -0.50x | $-28.22 Million | $56.37 Million | ▼ -87.2% |
| 2020 | -0.27x | $-21.37 Million | $79.90 Million | ▼ -232.5% |
| 2019 | -0.08x | $-21.73 Million | $270.17 Million | ▼ -7.9% |
| 2018 | -0.07x | $-17.68 Million | $237.09 Million | — |